speb/financial-data huggingface dataset:
20MICRONS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -168479000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -47673000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 1000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -1000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 2995677000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2995677000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -753178000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 256659000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 4279541000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4279541000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 12610000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 12610000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 276167000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 276167000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 8997000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 8997000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 54697000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 54697000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1143639000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 241016000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Normalized Income: 639506988.17
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 154189699.91
20MICRONS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 317864000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Operating Income: 1006005000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 240251000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 9116589000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2274052000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 35286502.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 35286502.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 409000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 409000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 4117205000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 4117205000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 14097000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 14097000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 168452000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 76335000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 76335000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -2000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -2000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 12258000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2315000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 19151000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 558357000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 61525000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 61525000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 253826000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 253826000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 8543000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 8543000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 80978000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 80978000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Other Special Charges: 18335000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 2495000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Payables: 756804000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 756804000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7472000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7472000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 176712000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 176712000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Pretax Income: 826977000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 190848000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Properties: 1147000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 1147000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -9802000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -20000000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -766800000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1308394000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1308394000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 5845041000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1289926000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 182584000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 52600000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 69582000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 259000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 259000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 3390686000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3390686000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 146568000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 25026000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 13622000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1300494000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1454423000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 35286502.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 35286502.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Special Income Charges: -20837000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -2495000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 4293638000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4293638000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4279541000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4279541000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -5093011.83
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -506300.09
20MICRONS.NS income_statement (annual, 2025-03-31) — Tax Provision: 202131000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 38728000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.24
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.20
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 92680000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 92680000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -216081000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 7145086000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 7145086000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 4515717000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4515717000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1648262000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1648262000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 4340545000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4340545000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Total Expenses: 8110584000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2033801000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 2804541000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2804541000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 3413715000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3413715000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 611473000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 611473000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 68370000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 11249000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 11249000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -20837000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -2495000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -20837000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -2495000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1538304000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1538304000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Write Off: 2502000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 855639000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2471649000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 35266736.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 4.78
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1348469000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 35266736.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 4.78
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 168575000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — EBIT: 275665000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 275665000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1123180000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 46967000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 46967000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -69000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Net Income: 168575000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 168575000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 168644000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 168575000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 168575000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 168644000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -46967000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -46967000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 275995000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 168818345.02
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 267541000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2471649000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 10948000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 641821000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Other Special Charges: 330000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 228698000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1348469000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: -330000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -86654.98
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 60054000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2204108000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -330000.00
20MICRONS.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -330000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 779816000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 2307829000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 607751000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1468522000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 28813000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 364945000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 35355691.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 4.92
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 119879000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 176433000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 493685000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 619194000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 176433000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4550592000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 206261000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1264090000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 3956573000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 26166000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1286891000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1313057000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2220166000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 12492000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 35355691.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 4.92
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 173950000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — EBIT: 279014000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — EBITDA: 279014000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14453000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3017983000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1043739000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 44453000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 44453000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1580232000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6064371000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 364945000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 21838000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 93713000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 226888000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 320601000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 21838000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 11599000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 33548000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 440000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1020094000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Net Income: 173950000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 173950000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 173511000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 173950000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 173950000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 173511000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -44453000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -44453000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 3017983000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4536139000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 10708000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 274132000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 279014000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 173950000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Operating Income: 263923000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2307829000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 35286502.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 257699000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 66661000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 4374159000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 14453000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 31107000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: -1000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 15340000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 572470000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2811722000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2113000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 125509000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Payables: 630887000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 234561000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1264090000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 35286502.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4550592000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4536139000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 61050000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 7417607000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4777480000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1633658000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4584140000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 2043906000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2833467000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3461034000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 613301000.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 23136000.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
20MICRONS.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
20MICRONS.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1736407000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 754136000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2148214000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 35273821.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 4.24
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1165871000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 35273821.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 4.24
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 149561000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — EBIT: 240094000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 240094000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 982343000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 40784000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 40784000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 876000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Net Income: 149561000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 149561000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 148684000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 149561000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 149561000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 148684000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -40784000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -40784000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 242424000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 151299165.27
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 228207000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2148214000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 15455000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 545605000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 2330000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 199310000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1165871000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -2330000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -591834.73
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 50626000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1920007000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -2330000.00
20MICRONS.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2330000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 2449918000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 848532000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9516757000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2610633000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 609227000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 609227000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1767097000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1767097000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -1906537000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1906537000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 395010000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 395010000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -17851000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -17851000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 4342000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 0.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 168640000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 168640000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 35286502.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 35304609.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Basic EPS: 18.94
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 4.99
20MICRONS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 312982000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 891401000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 891401000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -263589000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 101802000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 101802000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 176433000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 176433000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 735837000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 735837000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 832217000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 832217000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -44108000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 451014000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 451014000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 284823000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 284823000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 175356000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 177391000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 53557000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Change In Payable: -74575000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -334073000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 2178000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 422853000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 176433000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 176433000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 4836190000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4836190000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 127210000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 127210000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 6032266000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1496189000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 4169528000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 4169528000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 48651000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 48651000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1283741000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1283741000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1332392000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1332392000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 2170991000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2170991000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 1398000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 1398000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Depreciation: 200936000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 205278000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 35286502.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 35304609.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 18.94
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.99
20MICRONS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 668256000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 176170000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 364000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 364000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — EBIT: 1018019000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — EBIT: 283708000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — EBITDA: 1223297000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 283708000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 735836000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -303745000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 250466000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 250466000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 772360000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -7551000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 156473000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 15816000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 15816000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 1784948000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1784948000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 4982906000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4982906000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Gross Profit: 3484491000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1114444000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Held To Maturity Securities: 0.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 0.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Interest Expense: 110952000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 39210000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 110952000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 39210000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Interest Income: 16040000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 16040000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -171415000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 16040000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Inventory: 1422363000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1422363000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 6294428000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6294428000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -309351000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 168640000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 168640000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: 18888000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 18888000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 798460000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 798460000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 53151000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 53151000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 174497000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 174497000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 227648000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 227648000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 18888000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 18888000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 14748000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 14748000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 2909165000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2909165000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 32362000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 32362000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Minority Interests: 1557000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 310000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -48890000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Net Debt: 722401000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 722401000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -1224000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Net Income: 668256000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Net Income: 176170000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 668256000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 176170000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 666700000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 175860000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 668256000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 176170000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 668256000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 176170000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 912758000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 666700000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 175860000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Net Interest Income: -155375000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -39210000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -5160000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -52579000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -47582000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -155375000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -39210000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 3076369000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 3076369000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -251323000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -4997000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 4820374000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4820374000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 11457000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 11457000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 274142000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 274142000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 14748000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 14748000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 68822000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 68822000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1219042000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 285038000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Normalized Income: 665128548.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 177126628.68
20MICRONS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1035949000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Operating Income: 1034573000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 265912000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 9516757000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2610633000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 35286502.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 35286502.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 7297000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 7297000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: -2000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: -2000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 1000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 1000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 15816000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 15816000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 155375000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: -2000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -2000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: -1000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: -1000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 9568000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 20839000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 29674000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 627404000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Payable: 86032000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 86032000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 255523000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 255523000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 5335000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 5335000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 96380000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 96380000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Other Special Charges: -6064000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: 1330000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Payables: 707111000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 707111000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1398000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1398000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 82736000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 82736000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Pretax Income: 907067000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 244498000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Properties: 1147000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Properties: 1147000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -4804000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -48890000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -263589000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 1171897000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1171897000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 6032266000.00
20MICRONS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1496189000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 205278000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 57139000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 73210000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 364000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 364000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 3978873000.00
20MICRONS.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3978873000.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 0.00
20MICRONS.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 12266000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 1378444000.00
20MICRONS.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 1534917000.00
20MICRONS.NS balance_sheet (annual, 2026-03-31) — Share Issued: 35286502.00